Cortical pyramidal neurone loss may cause glutamatergic hypoactivity and cognitive impairment in Alzheimer's disease: investigative and therapeutic perspectives.
Francis
P T
PT
Miriam Marks Department of Neurochemistry, Institute of Neurology, London, England.
Sims
N R
NR
Procter
A W
AW
Bowen
D M
DM
D000544:Alzheimer Disease / Q000188:drug therapy* / Q000503:physiopathology* / Q000523:psychology; D002540:Cerebral Cortex / Q000473:pathology / Q000502:physiology*; D003072:Cognition Disorders / Q000209:etiology*; D005973:Glutamine / Q000502:physiology*; D006651:Histocytochemistry; D006801:Humans; D009410:Nerve Degeneration; D009448:Neurochemistry; D009474:Neurons / Q000473:pathology / Q000502:physiology*
D005973:Glutamine